ArticleJAMA network open2021

Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19.

Zara Izadi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.